文献速递美容整形

初次鼻整形患者中偏头痛与鼻窦性头痛的发生频率

Frequency of Migraine and Sinus Headaches in Patients Undergoing Primary Rhinoplasty.
PubMed 文献 · Aesthet Surg J · 2026-01-01

该回顾性研究纳入190例初次鼻整形患者,采用术前问卷筛查偏头痛(MH)和鼻窦性头痛(SH)。33.68%患者有SH或MH,MH发生率18.42%高于全球报告的14%–15%,提示鼻整形术前筛查可同时改善头痛症状与美观目标。

要点

  • 初次鼻整形患者中33.68%自报鼻窦性头痛或偏头痛。
  • 偏头痛发生率为18.42%,高于全球报告的14%–15%。
  • 术前筛查鼻源性头痛有助于在鼻整形中同时缓解症状。

核心结论

  • 该样本中偏头痛发生率18.42%高于全球报告的14%–15%。
  • 筛查并治疗鼻源性偏头痛和鼻窦性头痛可同时缓解症状并实现美学目标。

研究设计与样本

  • 回顾性研究,连续纳入190例初次鼻整形患者(女164例,86.32%;男26例,13.68%)。
  • 采用资深作者的2页术前问卷识别自报偏头痛和鼻窦性头痛的患者。

主要发现

  • 64例(33.68%)有鼻窦性头痛或偏头痛。
  • 29例(15.26%)仅有鼻窦性头痛,12例(6.32%)仅有偏头痛,23例(12.11%)两者均有。
  • 35例(18.42%)有偏头痛伴或不伴鼻窦性头痛。

临床怎么用

  • 鼻整形术前应询问偏头痛和鼻窦性头痛病史。
  • 对鼻源性头痛患者,鼻中隔鼻整形可能同时改善头痛症状和外观。

局限性

  • 证据等级为4级(治疗性)。
  • 为回顾性研究,依赖患者自报问卷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nearly two-thirds of patients who suffer from migraine headaches (MHs) have a rhinogenic trigger site. Most rhinoplasty patients are female, and an estimated 18% of females suffer from MHs. Rhinogenic MHs and sinus headaches (SHs) are commonly triggered by elements that can be readily addressed during septorhinoplasty. Consequently, this surgery may present a dual opportunity to address MH/SH and cosmetic concerns simultaneously. OBJECTIVES: The aim of this study was to quantify the incidence of MH and SH in patients presenting for primary rhinoplasty. METHODS: A retrospective review was conducted on a consecutive sample of patients who presented for primary rhinoplasty. The senior author's 2-page preoperative questionnaire which inquires about MHs and SHs was used to identify patients who self-reported MHs and SHs. MH and SH incidences were calculated as a percentage of the total number of patient responses. RESULTS: A total of 190 primary rhinoplasty patients (164 females [86.32%] and 26 males [13.68%]) completed preoperative questionnaires and were included in this study. In total, 64 patients (33.68%) had either SHs or MHs: 29 (15.26%) had SHs only, 12 (6.32%) had MHs only, and 23 (12.11%) had both MHs and SHs; 35 (18.42%) had MHs with or without SHs. CONCLUSIONS: MH incidence (18.42%) in this patient sample was greater than the reported global migraine rate of 14% to 15%. By screening for and treating rhinogenic MHs and SHs, surgeons can alleviate symptoms while fulfilling aesthetic objectives. LEVEL OF EVIDENCE: 4 (THERAPEUTIC): For image description, please refer to the figure legend and surrounding text.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Cvelbar R, Fodor R, Fraiman E, et al. Frequency of Migraine and Sinus Headaches in Patients Undergoing Primary Rhinoplasty. Aesthet Surg J. 2026. PMID: 41540720. doi:10.1093/asj/sjag006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。